Advertisement
PerkinElmer
PerkinElmer

The Scientist

» Big Pharma and immunology

Most Recent

image: HIV’s Stealth Revealed

HIV’s Stealth Revealed

By | November 21, 2013

HIV-1 evades the immune system with a protein shield, which can be lifted.

2 Comments

image: T cells and Transplantation

T cells and Transplantation

By | November 13, 2013

Drug-resistant immune cells protect patients from graft-versus-host disease after bone marrow transplant.

0 Comments

image: Time for T cells

Time for T cells

By | November 7, 2013

Circadian rhythms control the development of inflammatory T cells, while jet lag sends their production into overdrive.

1 Comment

image: Newborn Immune Systems Suppressed

Newborn Immune Systems Suppressed

By | November 6, 2013

Cells that temporarily restrain their immune systems give babies’ gut bacteria a chance to settle down. 

1 Comment

image: Frisky Fruit Flies

Frisky Fruit Flies

By | November 5, 2013

Researchers show that Drosophila females upregulate an immune gene for protection against sexually transmitted infections before copulation.

1 Comment

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers find strong correlations between the composition of the human microbiome and genetic variation in immune-related pathways.

4 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Brain on Fear
    The Scientist The Brain on Fear

    Scientists uncover the neurons in the mouse brain responsible for linking the sight of a looming object to scared behavior.

Advertisement
Eppendorf
Eppendorf
Advertisement
The Scientist